- Exempt U.K.-origin pharmaceuticals, pharmaceutical ingredients, and medical technology from Section 232 tariffs;
- Refrain from targeting U.K. pharmaceutical pricing practices in any future Section 301 investigation for the
On November 20, 2025, the White House issued an Executive Order marking a significant shift in U.S. trade policy toward Brazil. This action updates the measures originally imposed under Executive Order 14323 from July 30, 2025, which had established a 40% additional ad valorem duty on certain Brazilian goods under the International Emergency Economic Powers Act (IEEPA) due to concerns over Brazil’s policies and practices impacting U.S. national security and foreign policy.
Following the U.S. and China trade meetings last week, President Trump issued an Executive Order reducing the rate of fentanyl-related tariffs on China from 20% to 10%, effective November 10, 2025. These tariffs were originally imposed under the International Emergency Economic Powers Act (“IEEPA”) on February 1 and March 3, 2025 to address China’s failure to alleviate the influx of synthetic opioids into the U.S.
U.S. Launches Section 301 Investigation into China’s Phase One Trade Agreement Compliance
On October 24, 2025, U.S. Trade Representative Jamieson Greer announced the launch of a Section 301 investigation into China’s implementation of its commitments under the phase one trade agreement, which was singed on January 15, 2020, in response to the U.S. imposing up to 25% in Section 301 duties.
President Trump has issued a proclamation under Section 232 of the Trade Expansion Act of 1962 (“Section 232”) that sets October 14, 2025 as the effective date for Section 232 tariffs on softwood timber and lumber, upholstered wooden furniture, kitchen cabinets and vanities.
Imports of softwood timber and lumber will face a 10% ad…
The U.S. Supreme Court has agreed to review the legality of tariffs imposed by President Trump under the International Emergency Economic Powers Act (IEEPA). This decision follows a series of lower court rulings that challenge the extent of presidential authority in trade matters, particularly concerning the imposition of tariffs without express congressional approval.
In May…
On September 4, 2025, President Trump, using his authority under the International Emergency Economic Powers Act (“IEEPA”), issued an executive order (“EO”) titled, Implementing The United States–Japan Agreement, to implement the trade agreement with Japan on July 22, 2025. The EO establishes a15% tariff on the majority of Japanese imports, notably including automobiles and auto parts that have previously been central to U.S.–Japan trade tensions. Under the EO, all Japanese automobiles and auto components entering the United States will face a minimum 15% tariff, unless their current tariff rate is already at or above that level, in which case no additional duties will be imposed. The EO also provides for targeted exemptions for aerospace products, certain natural resources, and generic pharmaceuticals, which will be subject to zero tariffs. These tariffs are retroactively applied to goods imported for consumption from August 7, 2025, onward.